Lv11
50 积分 2025-07-25 加入
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
6小时前
待确认
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
2个月前
已完结
Efficacy and safety of PI3K/Akt/mTOR inhibitors combined with trastuzumab therapy for HER2-positive breast cancer: a meta-analysis
2个月前
已完结
皖公网安备34019202002308
